-
EP4329744
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4329744
| EP4329744 - SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-5-(1-PIPERIDIN-4-YL)ISOINDOLINE-1,3-DIONE DERIVATIVES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.02.2024 Database last updated on 30.10.2024 | |
| Former | The international publication has been made Status updated on 05.11.2022 | Most recent event Tooltip | 05.07.2024 | Change: Validation states | published on 07.08.2024 [2024/32] | 05.07.2024 | Change - extension states | published on 07.08.2024 [2024/32] | Applicant(s) | For all designated states Neomorph, Inc. 5590 Morehouse Drive San Diego, CA 92121 / US | For all designated states Dana-Farber Cancer Institute, Inc. 450 Brookline Avenue Boston, MA 02215-5450 / US | [2024/10] | Inventor(s) | 01 /
PETRILLI, Whitney L. San Diego, CA 92121 / US | 02 /
JONES, Lyn, Howard Winchester, MA 01890 / US | 03 /
LIU, Hu Newton, MA 02460 / US | [2024/10] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2024/10] | Application number, filing date | 22796823.7 | 29.04.2022 | [2024/10] | WO2022US26977 | Priority number, date | US202163181834P | 29.04.2021 Original published format: US 202163181834 P | [2024/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022232536 | Date: | 03.11.2022 | Language: | EN | [2022/44] | Type: | A1 Application with search report | No.: | EP4329744 | Date: | 06.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2022 takes the place of the publication of the European patent application. | [2024/10] | Search report(s) | International search report - published on: | US | 03.11.2022 | Classification | IPC: | A61K31/395, A61P19/02, A61P25/00 | [2024/10] | CPC: |
A61P19/02 (EP);
C07D417/14 (EP,US);
A61K31/4545 (EP,US);
A61K31/497 (US);
A61K31/498 (US);
A61K31/501 (US);
A61K31/506 (US);
A61K31/517 (US);
A61K31/519 (US);
A61K31/5377 (US);
A61K31/5415 (US);
A61K45/06 (EP);
C07D401/14 (EP,US);
C07D405/14 (EP,US);
C07D413/14 (EP,US);
C07D451/06 (EP);
C07D471/04 (EP,US);
C07D491/048 (EP,US);
C07D495/04 (EP,US)
(-)
| C-Set: |
A61K31/4545, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/10] | Title | German: | SUBSTITUIERTE 2-(2,6-DIOXOPIPERIDIN-3-YL)-5-(1-PIPERIDIN-4-YL)ISOINDOLIN-1,3-DIONDERIVATE UND VERWENDUNGEN DAVON | [2024/10] | English: | SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-5-(1-PIPERIDIN-4-YL)ISOINDOLINE-1,3-DIONE DERIVATIVES AND USES THEREOF | [2024/10] | French: | DÉRIVÉS DE 2-(2,6-DIOXOPIPÉRIDIN-3-YL)-5-(1-PIPÉRIDIN-4-YL)ISOINDOLINE-1,3-DIONE SUBSTITUÉS ET LEURS UTILISATIONS | [2024/10] | Entry into regional phase | 21.11.2023 | National basic fee paid | 21.11.2023 | Search fee paid | 21.11.2023 | Designation fee(s) paid | 21.11.2023 | Examination fee paid | Examination procedure | 21.11.2023 | Examination requested [2024/10] | 05.06.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 18.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2019062309 (BECKWITH ROHAN ERIC JOHN [US], et al); | [Y]WO2020165833 (NOVARTIS AG [CH]); |